Abstract

Background

Few studies examine how patients with advanced cancer cope with stress. The objective of our study was to evaluate coping strategies adopted by patients with cancer and their relationship with symptom burden.

Methods

A secondary data analysis of a prospective cross-sectional survey of patients with cancer and tobacco use was conducted, which examined demographics, symptom burden (Edmonton Symptom Assessment System), and coping strategies (the Brief COPE Questionnaire). Demographic characteristics were summarized by standard summary statistics; we also examined associations between patient characteristics and coping strategies using t-test, rank-sum test, chi-squared test, or Fisher’s exact test depending on the distribution of data.

Results

Among 399 patients, the majority were female (60%), Caucasian (70%), the mean age was 56.5 (±12.0) years, and the most common malignancies were gastrointestinal (21%) and breast (19%). Patients with cancer adopted multiple adaptive coping strategies, most frequently acceptance (86.7%) and emotional support (79.9%), with humor (18.5%) being the least. Common maladaptive strategies included venting (14.5%) and self-distraction (36.6%), while substance use (1.0%) was infrequently reported. Of the adaptive strategies, female gender was significantly associated with higher engagement with emotional and instrumental support, positive reframing, religious coping, and acceptance (P < .05 for all). College educated patients reported significantly higher implementation of humor, planning, and acceptance. Maladaptive coping strategies such as denial were associated with increased pain and depression, while patients adopting emotional-focused strategies rated decreased emotional distress.

Conclusions

The majority of patients with advanced cancer reported adopting multiple, adaptive coping strategies, and a minority utilized maladaptive or avoidant strategies, rarely substance use, and may need additional psychological support.

Implications for Practice

The majority of patients with advanced cancer reported implementing multiple adaptive as opposed to maladaptive or avoidant coping strategies. Patients with cancer with advanced disease who adopted problem-focused or maladaptive coping strategies including venting and denial were reported to have a higher symptom burden, while patients engaged in emotion-focused coping strategies reported less anxiety and depression. Identifying patients with cancer with unhealthy coping mechanisms is critical to direct psychological support and encourage alternative approach-orientated or emotion-focused strategies to cope with stress.

Introduction

The term coping is a broad concept used to describe a wide variety of cognitive and behavioral strategies to manage situations or emotions that are either internally or externally overwhelming.1 Several coping strategies and classification systems have been proposed to better understand and categorize how people cope with stressful situations; however, no consensus has been agreed upon.

Forerunners in distinguishing these strategies, Folkman and Lazarus classified coping into 4 groups including problem-focused, emotion-focused, support-seeking, and meaning-making.2 Various coping strategies can further be identified as either healthy (positive, adaptive or constructive, approach orientated or engaged) resulting in reduced distress, or unhealthy (negative, maladaptive, disengaged, or avoidant).3-5 As more research has been conducted, some academics have questioned the psychometric validity of the categorization of coping mechanisms,2 noting that people’s responses to stress are often complex and multidimensional. Investigators also reported that people adopted various coping strategies, often using several strategies simultaneously, and noted a high likelihood of changing strategies over time.1,6 In addition, the complexities of coping, and its effectiveness, are likely to be influenced by an individual’s unique personality as well as their social environment.1

Unfortunately, research on coping strategies among patients with advanced cancer is limited. One study of female patients with recurrent breast cancer found their coping capacity to be a predictor of the degree to which these patients experienced distress.7 Lower coping capacities were noted in patients who had higher emotional distress and worse QOL.7 In a study of men with prostate cancer who adopted avoidance coping strategies (behavioral disengagement, denial, and distraction) reported increased sleep disorders.8

In addition, religion and substance use—the use of alcohol or other drugs to deal with stress—have been found to impact coping. Negative religious coping, characterized by feeling abandoned or punished by God, was associated with psychological distress and worse QOL.9 Also, history or active tobacco use in patients with cancer was noted to be significantly associated with increased substance use as a coping strategy, pain and higher opioid use potentially increasing the patients risk for opioid-induced neurotoxicity.10

With a better understanding of how patients with advanced cancer cope, palliative care professionals can facilitate the adoption of health coping strategies or may intervene when patients adopt maladaptive or avoidant strategies to decrease symptom burden and psychological distress, and improve quality of life.11 The objective of our study was to evaluate coping strategies in patients with advanced cancer, and identify patient characteristics of those who adopted unhealthy, maladaptive strategies, and associated symptom burden.

Methods

We prospectively screened 490 consecutive patients with advanced cancer who were evaluated in an outpatient supportive care center (SCC) from 2015 to 2016. A total of 441 patients who attended at least 1 follow-up visit in our SCC were eligible to participate in the study. A total of 399, out of the 400 enrolled in the study, completed the survey. Fig. 1 shows the CONSORT diagram. Eligible patients had a diagnosis of advanced cancer and were ≥18 years of age. Advanced cancer was defined as locally advanced, metastatic, or locally recurrent disease for solid tumors and primary progressive or recurrent/refractory disease for hematologic malignancies. Patients with cancer with locally advanced disease and who received curative surgery or definitive chemoradiation as defined by no evidence of disease were excluded.

Consolidated Standards Of Reporting Trials (CONSORT) diagram.
Figure 1.

Consolidated Standards Of Reporting Trials (CONSORT) diagram.

Previously published findings reported patients with cancer who had a history of tobacco use had increased pain expression and higher daily opioid use.10 In this study, we conducted a secondary analysis examining various coping behaviors assessed using the Brief COPE Questionnaire12 in patients with advanced cancer, associated patient characteristics, and symptom burden.

Data Collection

We collected baseline patient demographics including age, sex, ethnicity, and marital status. Data regarding the primary cancer type including the date of diagnosis of advanced cancer and location of the primary cancer, stage of disease at the time of initial SCC consultation, and follow-up dates were documented.

Assessments collected included the Edmonton Symptom Assessment System (ESAS),13 the CAGE alcoholism screening questionnaire,14 the Brief COPE questionnaire,12 and the patient’s morphine equivalent daily dosing (MEDD). All participating patients were informed that their responses to the questions were completely confidential and would not affect the clinical care or treatment provided by the healthcare team.

The ESAS scores the severity of 10 symptoms (pain, fatigue, nausea, depression, anxiety, drowsiness, dyspnea, anorexia, feeling of well-being, and insomnia) on a numerical scale from 0 to 10 in which 0 indicates no symptoms and 10 indicates the worst possible symptom intensity.13

The Brief COPE is a self-reported, validated, 28-item questionnaire that evaluates state coping, which is the number of ways an individual copes in response to a specific stressful situation (such as a cancer diagnosis).12 It consists of 14 subscales (2 items per subscale) measuring the following: self-distraction, active coping, denial, substance use, use of emotional support, use of instrumental support, behavioral disengagement, venting, positive reframing, planning, humor, acceptance, religion, and self-blame. Cronbach alphas range from 0.50 to 0.90 for the Brief COPE subscales. Each single item is scored along a 4-point scale with the following options: 1 (I usually don’t do this at all); 2 (I usually do this a little bit); 3 (I usually do this a medium amount); and 4 (I usually do this a lot). The following 8 subscales are classified as adaptive strategies: active coping, planning, positive reframing, acceptance, humor, religion, use of emotional support, and use of instrumental support (Fig. 2). The remaining 6 subscales are noted to be unhealthy, maladaptive, and include self-distraction, denial, venting, substance use, behavioral disengagement, and self-blame.15,16 The maximum score for the 14 subscales is 8 points, with a higher score indicating greater use of a specific coping strategy. The Brief COPE has been used previously to assess styles of coping in patients with breast cancer,6 primary caregivers of patients with Alzheimer’s disease,17 symptomatic men infected with the human immunodeficiency virus,18 and hematological malignancies.19,20

Sub-classifications of coping strategies as outlined by brief-cope questionnaire.
Figure 2.

Sub-classifications of coping strategies as outlined by brief-cope questionnaire.

The CAGE questionnaire is a validated 4-item screening tool for a history of alcoholism and has been reported to be approximately 85% sensitive and 90% specific for the diagnosis of alcohol use disorder or dependence.10 The questionnaire asks the following: (1) Have you ever felt you needed to cut down on drinking? (2) Have people annoyed you by criticizing your drinking? (3) Have you ever felt Guilty about drinking? and (4) Have you ever felt you needed a drink in the morning (eye-opener)?

All patients provided informed consent prior to participation in the survey and the institutional review board at The University of Texas MD Anderson Cancer Center in Houston approved the study.

Statistical Analysis

Demographic and clinical characteristics of the study population were summarized with standard summary statistics. The characteristics of patients were compared by various subscales of coping strategies using t-test, rank-sum test, chi-squared test, or Fisher’s exact test depending on the underlying distribution of the data. An average score was calculated for each of the adaptive and maladaptive measures and were compared using a sign rank test. Logistic regression models were conducted to estimate the odds ratio along with 95% CI of subscales of coping strategies having a score greater than or equal to 6. Univariate models were conducted, and a final multivariable model was conducted based on univariate results and included variables with P-values <.10. All statistical analyses were performed using Stata/MP v17.0.

Results

A total of 399 consecutive patients (90%) out of the 441 approached completed the comprehensive questionnaire. Table 1 summarizes patient characteristics. Among 399 patients, the most common malignancies were gastrointestinal (21%) and breast (19%). Most patients (72%) had an advanced degree or some college education, were Caucasian (69.4%), were female gender (56%), and had metastatic or recurrent cancer (91.5%).

Table 1.

Baseline characteristics of patients with advanced cancer.

Patient characteristicsTotal N = 399 (%)
Age (mean ± SD)56.5 (±12.0)
Cancer type
 Breast78 (19.5)
 Gastrointestinal84 (21.1)
 Genito-urinary41 (10.3)
 Gynecological42 (10.5)
 Head and neck46 (11.5)
 Thoracic50 (12.5)
 Leukemia and other58 (14.5)
Education
 Some college or more287 (72.3)
 High school or less110 (27.7)
Ethnicity
 White277 (69.4)
 African American71 (17.8)
 Hispanic and other51 (12.8)
Gender
 Female223 (55.9)
Marital status
 Married or living with partner263 (63.9)
Stage of cancer
 Locally advanced34 (8.5)
 Metastatic/recurrent365 (91.5)
CAGE positive (≥2)70 (17.5)
Zubrod performance status
(mean ± SD)
1.9 (± 0.7)
Patient characteristicsTotal N = 399 (%)
Age (mean ± SD)56.5 (±12.0)
Cancer type
 Breast78 (19.5)
 Gastrointestinal84 (21.1)
 Genito-urinary41 (10.3)
 Gynecological42 (10.5)
 Head and neck46 (11.5)
 Thoracic50 (12.5)
 Leukemia and other58 (14.5)
Education
 Some college or more287 (72.3)
 High school or less110 (27.7)
Ethnicity
 White277 (69.4)
 African American71 (17.8)
 Hispanic and other51 (12.8)
Gender
 Female223 (55.9)
Marital status
 Married or living with partner263 (63.9)
Stage of cancer
 Locally advanced34 (8.5)
 Metastatic/recurrent365 (91.5)
CAGE positive (≥2)70 (17.5)
Zubrod performance status
(mean ± SD)
1.9 (± 0.7)
Table 1.

Baseline characteristics of patients with advanced cancer.

Patient characteristicsTotal N = 399 (%)
Age (mean ± SD)56.5 (±12.0)
Cancer type
 Breast78 (19.5)
 Gastrointestinal84 (21.1)
 Genito-urinary41 (10.3)
 Gynecological42 (10.5)
 Head and neck46 (11.5)
 Thoracic50 (12.5)
 Leukemia and other58 (14.5)
Education
 Some college or more287 (72.3)
 High school or less110 (27.7)
Ethnicity
 White277 (69.4)
 African American71 (17.8)
 Hispanic and other51 (12.8)
Gender
 Female223 (55.9)
Marital status
 Married or living with partner263 (63.9)
Stage of cancer
 Locally advanced34 (8.5)
 Metastatic/recurrent365 (91.5)
CAGE positive (≥2)70 (17.5)
Zubrod performance status
(mean ± SD)
1.9 (± 0.7)
Patient characteristicsTotal N = 399 (%)
Age (mean ± SD)56.5 (±12.0)
Cancer type
 Breast78 (19.5)
 Gastrointestinal84 (21.1)
 Genito-urinary41 (10.3)
 Gynecological42 (10.5)
 Head and neck46 (11.5)
 Thoracic50 (12.5)
 Leukemia and other58 (14.5)
Education
 Some college or more287 (72.3)
 High school or less110 (27.7)
Ethnicity
 White277 (69.4)
 African American71 (17.8)
 Hispanic and other51 (12.8)
Gender
 Female223 (55.9)
Marital status
 Married or living with partner263 (63.9)
Stage of cancer
 Locally advanced34 (8.5)
 Metastatic/recurrent365 (91.5)
CAGE positive (≥2)70 (17.5)
Zubrod performance status
(mean ± SD)
1.9 (± 0.7)

In general, adaptive coping strategies were adopted by patients with advanced cancer more frequently than maladaptive strategies (mean score [SD]; 5.7 [1.1] vs. 3.2 [0.7], respectively). Table 2 summarizes patient coping strategies and associated symptom burden as measured by the ESAS. Of the adaptive coping strategies, patients with cancer incorporated at moderate to high frequency (% patients with ≥6 score on Brief Cope subscale) included acceptance (86.7%), emotional support (79.9%), religion (69.4%), active coping (62.4%), instrumental support (48.4%), positive reframing (48.6%), planning (49.6%), and less commonly, humor (18.5%). Negative or maladaptive coping strategies that were adopted at moderate to high frequency included self-distraction (36.6%) and venting (14.5%), while self-blame (6.3%), denial (4.5%), behavioral disengagement (1.8%), and substance use (1.0%) were infrequently reported.

Table 2.

Coping styles of patients with advanced cancer and associated symptom burden.

Coping strategiesBrief COPE score
n = 399
(mean ± SD)
Number of patients with medium to high adoption (≥6) (%)Significant symptom scores ESAS (0-10)
Mean (±SD)
SymptomLow utilizationMedium-High utilizationP-valuea
AdaptiveProblem-focusedActive Coping6.0 ± 1.7249 (62.4)No significant differences in symptom burden (>0.1)
Planning5.4 ± 1.8198 (49.6)Pain3.7 (2.7)4.2 (2.7).08
Fatigue4.0 (2.7)4.6 (2.9).04
Anxiety1.7 (2.2)2.6 (2.8)<.001
Depression1.5 (2.0)2.2 (2.6).004
Drowsiness2.4 (2.5)2.8 (2.7).08
Sleep3.5 (2.5)4.1 (2.7).02
Wellbeing3.3 (2.3)4.0 (2.6).006
Instrumental support5.3 ± 1.8185 (48.4)Drowsiness2.4 (2.7)2.9 (2.6).04
Dyspnea1.8 (2.5)2.3 (2.6).05
Sleep3.5 (2.5)4.2 (2.7).01
Wellbeing3.4 (2.5)3.8 (2.4).06
Emotion-focusedPositive reframing5.5 ± 1.9194 (48.6)Fatigue4.5 (2.8)4.1 (2.8).10
Sleep3.6 (2.5)4.1 (2.7).09
Wellbeing3.8 (2.4)3.4 (2.5).08
Emotional support6.8 ± 1.6319 (79.9)Pain4.5 (2.7)3.9 (2.7).06
Anxiety2.6 (2.9)2.0 (2.3).03
Depression2.6 (2.9)1.7 (2.1).03
Nausea2.2 (2.7)1.7 (2.3).08
Humor3.7 ± 1.974 (18.6)Anxiety2.1 (2.5)2.7 (2.7).08
Depression1.8 (2.3)2.2 (2.3).05
Acceptance7.0 ± 1.3346 (86.7)Anxiety2.2 (2.8)2.0 (2.4).01
Depression2.9 (3.3)1.7 (2.2).003
Nausea2.7 (2.8)1.6 (2.2).005
Religion6.4 ± 1.9277 (69.4)Depression2.3 (2.5)1.7 (2.3).03
Appetite4.2 (2.8)3.5 (2.9).01
Sleep4,2 (2.5)2.7 (2.7).05
Wellbeing4.0 (2.5)3.5 (2.4).09
 MaladaptiveSubstance use2.2 ± 0.84 (1.0)Small sample size
Self-blame2.9 ± 1.425 (6.3)Anxiety2.1 (2.5)2.8 (2.7).10
Denial2.6 ± 1.318 (4.5)Pain3.9 (2.7)6.0 (2.3).001
Anxiety2.1 (2.4)4.3 (3.4).01
Depression1.7 (2.2)4.2 (3.3).001
Nausea1.7 (2.4)3.1 (3.4).05
Venting3.8 ± 1.558 (14.5)Anxiety2.0 (2.5)3.0 (2.9).01
Depression1.7 (2.3)2.5 (2.7).02
Behavioral disengagement2.3 ± 0.97 (1.8)Small sample size
Self-distraction4.9 ± 1.6146 (36.6)Depression1.7 (2.4)2.1 (2.3).03
Dyspnea2.3 (2.7)1.7 (2.3).05
Sleep3.7 (2.5)4.1 (2.7).08
Coping strategiesBrief COPE score
n = 399
(mean ± SD)
Number of patients with medium to high adoption (≥6) (%)Significant symptom scores ESAS (0-10)
Mean (±SD)
SymptomLow utilizationMedium-High utilizationP-valuea
AdaptiveProblem-focusedActive Coping6.0 ± 1.7249 (62.4)No significant differences in symptom burden (>0.1)
Planning5.4 ± 1.8198 (49.6)Pain3.7 (2.7)4.2 (2.7).08
Fatigue4.0 (2.7)4.6 (2.9).04
Anxiety1.7 (2.2)2.6 (2.8)<.001
Depression1.5 (2.0)2.2 (2.6).004
Drowsiness2.4 (2.5)2.8 (2.7).08
Sleep3.5 (2.5)4.1 (2.7).02
Wellbeing3.3 (2.3)4.0 (2.6).006
Instrumental support5.3 ± 1.8185 (48.4)Drowsiness2.4 (2.7)2.9 (2.6).04
Dyspnea1.8 (2.5)2.3 (2.6).05
Sleep3.5 (2.5)4.2 (2.7).01
Wellbeing3.4 (2.5)3.8 (2.4).06
Emotion-focusedPositive reframing5.5 ± 1.9194 (48.6)Fatigue4.5 (2.8)4.1 (2.8).10
Sleep3.6 (2.5)4.1 (2.7).09
Wellbeing3.8 (2.4)3.4 (2.5).08
Emotional support6.8 ± 1.6319 (79.9)Pain4.5 (2.7)3.9 (2.7).06
Anxiety2.6 (2.9)2.0 (2.3).03
Depression2.6 (2.9)1.7 (2.1).03
Nausea2.2 (2.7)1.7 (2.3).08
Humor3.7 ± 1.974 (18.6)Anxiety2.1 (2.5)2.7 (2.7).08
Depression1.8 (2.3)2.2 (2.3).05
Acceptance7.0 ± 1.3346 (86.7)Anxiety2.2 (2.8)2.0 (2.4).01
Depression2.9 (3.3)1.7 (2.2).003
Nausea2.7 (2.8)1.6 (2.2).005
Religion6.4 ± 1.9277 (69.4)Depression2.3 (2.5)1.7 (2.3).03
Appetite4.2 (2.8)3.5 (2.9).01
Sleep4,2 (2.5)2.7 (2.7).05
Wellbeing4.0 (2.5)3.5 (2.4).09
 MaladaptiveSubstance use2.2 ± 0.84 (1.0)Small sample size
Self-blame2.9 ± 1.425 (6.3)Anxiety2.1 (2.5)2.8 (2.7).10
Denial2.6 ± 1.318 (4.5)Pain3.9 (2.7)6.0 (2.3).001
Anxiety2.1 (2.4)4.3 (3.4).01
Depression1.7 (2.2)4.2 (3.3).001
Nausea1.7 (2.4)3.1 (3.4).05
Venting3.8 ± 1.558 (14.5)Anxiety2.0 (2.5)3.0 (2.9).01
Depression1.7 (2.3)2.5 (2.7).02
Behavioral disengagement2.3 ± 0.97 (1.8)Small sample size
Self-distraction4.9 ± 1.6146 (36.6)Depression1.7 (2.4)2.1 (2.3).03
Dyspnea2.3 (2.7)1.7 (2.3).05
Sleep3.7 (2.5)4.1 (2.7).08

at-test or rank-sum test.

Abbreviation: ESAS, Edmonton Symptom Assessment System (<2.5% missing symptom ratings).

Table 2.

Coping styles of patients with advanced cancer and associated symptom burden.

Coping strategiesBrief COPE score
n = 399
(mean ± SD)
Number of patients with medium to high adoption (≥6) (%)Significant symptom scores ESAS (0-10)
Mean (±SD)
SymptomLow utilizationMedium-High utilizationP-valuea
AdaptiveProblem-focusedActive Coping6.0 ± 1.7249 (62.4)No significant differences in symptom burden (>0.1)
Planning5.4 ± 1.8198 (49.6)Pain3.7 (2.7)4.2 (2.7).08
Fatigue4.0 (2.7)4.6 (2.9).04
Anxiety1.7 (2.2)2.6 (2.8)<.001
Depression1.5 (2.0)2.2 (2.6).004
Drowsiness2.4 (2.5)2.8 (2.7).08
Sleep3.5 (2.5)4.1 (2.7).02
Wellbeing3.3 (2.3)4.0 (2.6).006
Instrumental support5.3 ± 1.8185 (48.4)Drowsiness2.4 (2.7)2.9 (2.6).04
Dyspnea1.8 (2.5)2.3 (2.6).05
Sleep3.5 (2.5)4.2 (2.7).01
Wellbeing3.4 (2.5)3.8 (2.4).06
Emotion-focusedPositive reframing5.5 ± 1.9194 (48.6)Fatigue4.5 (2.8)4.1 (2.8).10
Sleep3.6 (2.5)4.1 (2.7).09
Wellbeing3.8 (2.4)3.4 (2.5).08
Emotional support6.8 ± 1.6319 (79.9)Pain4.5 (2.7)3.9 (2.7).06
Anxiety2.6 (2.9)2.0 (2.3).03
Depression2.6 (2.9)1.7 (2.1).03
Nausea2.2 (2.7)1.7 (2.3).08
Humor3.7 ± 1.974 (18.6)Anxiety2.1 (2.5)2.7 (2.7).08
Depression1.8 (2.3)2.2 (2.3).05
Acceptance7.0 ± 1.3346 (86.7)Anxiety2.2 (2.8)2.0 (2.4).01
Depression2.9 (3.3)1.7 (2.2).003
Nausea2.7 (2.8)1.6 (2.2).005
Religion6.4 ± 1.9277 (69.4)Depression2.3 (2.5)1.7 (2.3).03
Appetite4.2 (2.8)3.5 (2.9).01
Sleep4,2 (2.5)2.7 (2.7).05
Wellbeing4.0 (2.5)3.5 (2.4).09
 MaladaptiveSubstance use2.2 ± 0.84 (1.0)Small sample size
Self-blame2.9 ± 1.425 (6.3)Anxiety2.1 (2.5)2.8 (2.7).10
Denial2.6 ± 1.318 (4.5)Pain3.9 (2.7)6.0 (2.3).001
Anxiety2.1 (2.4)4.3 (3.4).01
Depression1.7 (2.2)4.2 (3.3).001
Nausea1.7 (2.4)3.1 (3.4).05
Venting3.8 ± 1.558 (14.5)Anxiety2.0 (2.5)3.0 (2.9).01
Depression1.7 (2.3)2.5 (2.7).02
Behavioral disengagement2.3 ± 0.97 (1.8)Small sample size
Self-distraction4.9 ± 1.6146 (36.6)Depression1.7 (2.4)2.1 (2.3).03
Dyspnea2.3 (2.7)1.7 (2.3).05
Sleep3.7 (2.5)4.1 (2.7).08
Coping strategiesBrief COPE score
n = 399
(mean ± SD)
Number of patients with medium to high adoption (≥6) (%)Significant symptom scores ESAS (0-10)
Mean (±SD)
SymptomLow utilizationMedium-High utilizationP-valuea
AdaptiveProblem-focusedActive Coping6.0 ± 1.7249 (62.4)No significant differences in symptom burden (>0.1)
Planning5.4 ± 1.8198 (49.6)Pain3.7 (2.7)4.2 (2.7).08
Fatigue4.0 (2.7)4.6 (2.9).04
Anxiety1.7 (2.2)2.6 (2.8)<.001
Depression1.5 (2.0)2.2 (2.6).004
Drowsiness2.4 (2.5)2.8 (2.7).08
Sleep3.5 (2.5)4.1 (2.7).02
Wellbeing3.3 (2.3)4.0 (2.6).006
Instrumental support5.3 ± 1.8185 (48.4)Drowsiness2.4 (2.7)2.9 (2.6).04
Dyspnea1.8 (2.5)2.3 (2.6).05
Sleep3.5 (2.5)4.2 (2.7).01
Wellbeing3.4 (2.5)3.8 (2.4).06
Emotion-focusedPositive reframing5.5 ± 1.9194 (48.6)Fatigue4.5 (2.8)4.1 (2.8).10
Sleep3.6 (2.5)4.1 (2.7).09
Wellbeing3.8 (2.4)3.4 (2.5).08
Emotional support6.8 ± 1.6319 (79.9)Pain4.5 (2.7)3.9 (2.7).06
Anxiety2.6 (2.9)2.0 (2.3).03
Depression2.6 (2.9)1.7 (2.1).03
Nausea2.2 (2.7)1.7 (2.3).08
Humor3.7 ± 1.974 (18.6)Anxiety2.1 (2.5)2.7 (2.7).08
Depression1.8 (2.3)2.2 (2.3).05
Acceptance7.0 ± 1.3346 (86.7)Anxiety2.2 (2.8)2.0 (2.4).01
Depression2.9 (3.3)1.7 (2.2).003
Nausea2.7 (2.8)1.6 (2.2).005
Religion6.4 ± 1.9277 (69.4)Depression2.3 (2.5)1.7 (2.3).03
Appetite4.2 (2.8)3.5 (2.9).01
Sleep4,2 (2.5)2.7 (2.7).05
Wellbeing4.0 (2.5)3.5 (2.4).09
 MaladaptiveSubstance use2.2 ± 0.84 (1.0)Small sample size
Self-blame2.9 ± 1.425 (6.3)Anxiety2.1 (2.5)2.8 (2.7).10
Denial2.6 ± 1.318 (4.5)Pain3.9 (2.7)6.0 (2.3).001
Anxiety2.1 (2.4)4.3 (3.4).01
Depression1.7 (2.2)4.2 (3.3).001
Nausea1.7 (2.4)3.1 (3.4).05
Venting3.8 ± 1.558 (14.5)Anxiety2.0 (2.5)3.0 (2.9).01
Depression1.7 (2.3)2.5 (2.7).02
Behavioral disengagement2.3 ± 0.97 (1.8)Small sample size
Self-distraction4.9 ± 1.6146 (36.6)Depression1.7 (2.4)2.1 (2.3).03
Dyspnea2.3 (2.7)1.7 (2.3).05
Sleep3.7 (2.5)4.1 (2.7).08

at-test or rank-sum test.

Abbreviation: ESAS, Edmonton Symptom Assessment System (<2.5% missing symptom ratings).

Table 2 also reports trends and significant symptoms associated, on univariate analysis, with various classifications of coping mechanisms. Of the unhealthy, maladaptive strategies, patients who adopted venting either moderate to high were noted to significantly rate higher symptoms of anxiety (mean ESAS [0-10] [SD]); (3.0 [2.9] vs. 2.0 [2.5], P = .01) and depression (2.5 [2.7] vs. 1.7 [2.3], P = .02). Self-distraction was utilized by patients who rated depression significantly higher (2.1 [2.3] vs. 1.7 [2.4], P = .03) but noted less dyspnea (1.7 [2.3] vs. 2.3 [2.7)], P = .05). Patients who adopted denial at moderate to high frequency had higher ratings of pain (6.0 [2.3] vs. 3.9 [2.7], P = .001), worse nausea (3.1 [3.4] vs. 1.7 [2.4], P = .02), increased depression (4.2 [3.3] vs. 1.7 [2.2], P = .01), and elevated anxiety (4.3 [3.4] vs. 2.1 [2.4], P = .01).

Of the adaptive strategies, patients with cancer who engaged in emotional support either moderate to high degree reported significantly less anxiety (2.0 [2.3] vs. 2.6 [2.9], P = .03) and depression (1.7 [2.1] vs. 2.6 [2.9], P = .03). Patients who adopted instrumental support noted higher drowsiness (2.9 [2.6] vs. 2.4 [2.7], P = .04), increased dyspnea (2.3 [2.6] vs. 1.8 [2.5], P = .05), and worse sleep ratings (4.2 [2.7] vs. 3.5 [2.5], P = .01). Planning as a moderate to high coping strategy versus low adoption was associated with increased fatigue (4.6 [2.9] vs. 4.0 [2.7], P = .04), higher anxiety (2.6 [2.8] vs. 1.7 [2.2], P < .001), increased depression (2.2 [2.6] vs. 1.5 [2.0], P = .004), worse sleep (4.1 [2.7] vs. 3.5 [2.5], P = .02), and well-being (4.0 [2.6] vs. 3.3 [2.3], P = .006). Patients who implemented acceptance at moderate to high frequency rated less anxiety (2.0 [2.4] vs. 2.2 [2.8], P = .01) and depression (1.7 [2.2] vs. 2.9 [3.3], P = .003) as well as decreased nausea (91.7 [2.3] vs. 2.2 [2.7], P = .005). Patients who engaged in moderate to high religious coping versus low were noted to rate less depression (1.7 [2.3] vs. 2.3 [2.5], P = .03), better appetite (3.5 [2.9] vs. 4.2 [2.8], P = .01), and sleep (2.7 [2.7] vs. 4.2 [2.5], P = .05).

Table 3 reports the unadjusted and adjusted odds ratios for symptoms and associated with moderate to high adoption versus low of various subclassifications of coping strategies. Of note, patients with cancer who adopted denial at moderate to high frequency were noted to have higher depression (adjusted OR [95%CI]; 1.69 [1.15, 2.48], P = .007) and increased pain (1.38 [1.05, 1.81], P = .02). Patients who adopted positive reframing noted worse ratings of sleep (1.16 [1.05, 1.27], P = .002).

Table 3.

Symptom burden and subcategories of coping styles of patients with advanced cancer.

Coping strategiesMedium-high vs. low utilization
Symptom burdenOR [95%CI]
Unadjusted
P-valueOR [95%CI]
Adjusted
P-valuea
AdaptiveProblem-focusedActive copingNo significant differences in symptom burden (>0.1)
PlanningPain1.07 [1.00, 1.15].060.99 [0.90, 1.09].87
Fatigue1.08 [1.00, 1.16].041.02 [0.91, 1.14].72
Anxiety1.16 [1.07, 1.26] <.0011.06 [0.93, 1.21].37
Depression1.15 {1.06, 1.26].0021.04 [0.90, 1.21].59
Drowsiness1.07 [0.99, 1.15].081.00 [0.89, 1.11].97
Sleep1.10 [1.02, 1.18].021.07 [0.96, 1.18].21
Wellbeing1.13 [1.04, 1.23].0041.04 [0.92, 1.17].54
Instrumental supportPain1.07 [1.00, 1.16].061.04 [0.96, 1.13].33
Drowsiness1.07 [0.99, 1.15].091.02 [0.93, 1.11].66
Dyspnea1.07 [0.99, 1.16].091.03 [0.94, 1.12].52
Sleep1.10 [1.02, 1.19].011.08 [0.99, 1.17].10
Wellbeing1.08 [0.99, 1.17].081.01 [0.91, 1.11].88
Emotion-focusedPositive reframingPain0.94 [0.87, 1.01].100.96 [0.88, 1.04].34
Fatigue0.94 [0.88, 1.01].100.95 [0.88, 1.03].22
Sleep1.07 [0.99, 1.16].071.16 [1.05, 1.27].002
Emotional supportPain0.92 [0.84, 1.01].080.98 [0.89, 1.09].77
Fatigue0.93 [0.85, 1.01].100.99 [0.89, 1.12].92
Nausea0.92 [0.83, 1.01].070.97 [0.86, 1.09].63
Anxiety0.85 [0.78, 0.93].0010.90 [0.78, 1.03].13
Depression0.86 [0.78, 0.95].0030.95 [0.81, 1.11].50
HumorAnxiety1.09 [0.99, 1.19].081.09 [0.99, 1.20].09
AcceptanceAnxiety0.84 [0.78, 0.93].0010.92 [0.77, 1.10].38
Depression0.82 [0.74, 0.95] <.0010.90 [0.74, 1.09].27
Nausea0.86 [0.77, 0.95].0040.90 [0.79, 1.03].12
ReligionDepression0.91 [0.83, 0.99].040.92 [0.83, 1.02].12
Appetite0.91 [0.84, 0.98].020.94 [0.86, 1.03].20
Sleep0.92 [0.85, 1.00].060.96 [0.87, 1.06].39
Wellbeing0.92 [0.85, 1.01].081.01 [0.90, 1.14].82
MaladaptiveSubstance useSmall sample size
Self-blameNo significant differences in symptom burden (>0.1)
DenialPain1.34 [1.11, 1.62].0021.38 [1.05, 1.81].02
Nausea1.21 [1.04, 1.41].021.19 [0.97, 1.47].10
Anxiety1.30 [1.11, 1.51].0010.90 [0.66, 1.21].48
Depression1.48 [1.17, 1.64] <.0011.69 [1.15, 2.48].007
Dyspnea1.16 [0.99, 1.37].061.17 [0.93, 1.48].17
Wellbeing1.21 [1.00, 1.47].050.96 [0.73, 1.27].77
VentingAnxiety1.14 [1.03, 1.26].0091.10 [0.95, 1.28].22
Depression1.13 [1.02, 1.26].021.05 [0.90, 1.24].52
Behavioral disengagementSmall sample size
Self-distractionDyspnea0.91 [0.83, 0.99].030.92 [0.83, 1.01].09
Coping strategiesMedium-high vs. low utilization
Symptom burdenOR [95%CI]
Unadjusted
P-valueOR [95%CI]
Adjusted
P-valuea
AdaptiveProblem-focusedActive copingNo significant differences in symptom burden (>0.1)
PlanningPain1.07 [1.00, 1.15].060.99 [0.90, 1.09].87
Fatigue1.08 [1.00, 1.16].041.02 [0.91, 1.14].72
Anxiety1.16 [1.07, 1.26] <.0011.06 [0.93, 1.21].37
Depression1.15 {1.06, 1.26].0021.04 [0.90, 1.21].59
Drowsiness1.07 [0.99, 1.15].081.00 [0.89, 1.11].97
Sleep1.10 [1.02, 1.18].021.07 [0.96, 1.18].21
Wellbeing1.13 [1.04, 1.23].0041.04 [0.92, 1.17].54
Instrumental supportPain1.07 [1.00, 1.16].061.04 [0.96, 1.13].33
Drowsiness1.07 [0.99, 1.15].091.02 [0.93, 1.11].66
Dyspnea1.07 [0.99, 1.16].091.03 [0.94, 1.12].52
Sleep1.10 [1.02, 1.19].011.08 [0.99, 1.17].10
Wellbeing1.08 [0.99, 1.17].081.01 [0.91, 1.11].88
Emotion-focusedPositive reframingPain0.94 [0.87, 1.01].100.96 [0.88, 1.04].34
Fatigue0.94 [0.88, 1.01].100.95 [0.88, 1.03].22
Sleep1.07 [0.99, 1.16].071.16 [1.05, 1.27].002
Emotional supportPain0.92 [0.84, 1.01].080.98 [0.89, 1.09].77
Fatigue0.93 [0.85, 1.01].100.99 [0.89, 1.12].92
Nausea0.92 [0.83, 1.01].070.97 [0.86, 1.09].63
Anxiety0.85 [0.78, 0.93].0010.90 [0.78, 1.03].13
Depression0.86 [0.78, 0.95].0030.95 [0.81, 1.11].50
HumorAnxiety1.09 [0.99, 1.19].081.09 [0.99, 1.20].09
AcceptanceAnxiety0.84 [0.78, 0.93].0010.92 [0.77, 1.10].38
Depression0.82 [0.74, 0.95] <.0010.90 [0.74, 1.09].27
Nausea0.86 [0.77, 0.95].0040.90 [0.79, 1.03].12
ReligionDepression0.91 [0.83, 0.99].040.92 [0.83, 1.02].12
Appetite0.91 [0.84, 0.98].020.94 [0.86, 1.03].20
Sleep0.92 [0.85, 1.00].060.96 [0.87, 1.06].39
Wellbeing0.92 [0.85, 1.01].081.01 [0.90, 1.14].82
MaladaptiveSubstance useSmall sample size
Self-blameNo significant differences in symptom burden (>0.1)
DenialPain1.34 [1.11, 1.62].0021.38 [1.05, 1.81].02
Nausea1.21 [1.04, 1.41].021.19 [0.97, 1.47].10
Anxiety1.30 [1.11, 1.51].0010.90 [0.66, 1.21].48
Depression1.48 [1.17, 1.64] <.0011.69 [1.15, 2.48].007
Dyspnea1.16 [0.99, 1.37].061.17 [0.93, 1.48].17
Wellbeing1.21 [1.00, 1.47].050.96 [0.73, 1.27].77
VentingAnxiety1.14 [1.03, 1.26].0091.10 [0.95, 1.28].22
Depression1.13 [1.02, 1.26].021.05 [0.90, 1.24].52
Behavioral disengagementSmall sample size
Self-distractionDyspnea0.91 [0.83, 0.99].030.92 [0.83, 1.01].09

aWald test.

Abbreviation: ESAS, Edmonton Symptom Assessment System (<2.5% missing symptom ratings).

Table 3.

Symptom burden and subcategories of coping styles of patients with advanced cancer.

Coping strategiesMedium-high vs. low utilization
Symptom burdenOR [95%CI]
Unadjusted
P-valueOR [95%CI]
Adjusted
P-valuea
AdaptiveProblem-focusedActive copingNo significant differences in symptom burden (>0.1)
PlanningPain1.07 [1.00, 1.15].060.99 [0.90, 1.09].87
Fatigue1.08 [1.00, 1.16].041.02 [0.91, 1.14].72
Anxiety1.16 [1.07, 1.26] <.0011.06 [0.93, 1.21].37
Depression1.15 {1.06, 1.26].0021.04 [0.90, 1.21].59
Drowsiness1.07 [0.99, 1.15].081.00 [0.89, 1.11].97
Sleep1.10 [1.02, 1.18].021.07 [0.96, 1.18].21
Wellbeing1.13 [1.04, 1.23].0041.04 [0.92, 1.17].54
Instrumental supportPain1.07 [1.00, 1.16].061.04 [0.96, 1.13].33
Drowsiness1.07 [0.99, 1.15].091.02 [0.93, 1.11].66
Dyspnea1.07 [0.99, 1.16].091.03 [0.94, 1.12].52
Sleep1.10 [1.02, 1.19].011.08 [0.99, 1.17].10
Wellbeing1.08 [0.99, 1.17].081.01 [0.91, 1.11].88
Emotion-focusedPositive reframingPain0.94 [0.87, 1.01].100.96 [0.88, 1.04].34
Fatigue0.94 [0.88, 1.01].100.95 [0.88, 1.03].22
Sleep1.07 [0.99, 1.16].071.16 [1.05, 1.27].002
Emotional supportPain0.92 [0.84, 1.01].080.98 [0.89, 1.09].77
Fatigue0.93 [0.85, 1.01].100.99 [0.89, 1.12].92
Nausea0.92 [0.83, 1.01].070.97 [0.86, 1.09].63
Anxiety0.85 [0.78, 0.93].0010.90 [0.78, 1.03].13
Depression0.86 [0.78, 0.95].0030.95 [0.81, 1.11].50
HumorAnxiety1.09 [0.99, 1.19].081.09 [0.99, 1.20].09
AcceptanceAnxiety0.84 [0.78, 0.93].0010.92 [0.77, 1.10].38
Depression0.82 [0.74, 0.95] <.0010.90 [0.74, 1.09].27
Nausea0.86 [0.77, 0.95].0040.90 [0.79, 1.03].12
ReligionDepression0.91 [0.83, 0.99].040.92 [0.83, 1.02].12
Appetite0.91 [0.84, 0.98].020.94 [0.86, 1.03].20
Sleep0.92 [0.85, 1.00].060.96 [0.87, 1.06].39
Wellbeing0.92 [0.85, 1.01].081.01 [0.90, 1.14].82
MaladaptiveSubstance useSmall sample size
Self-blameNo significant differences in symptom burden (>0.1)
DenialPain1.34 [1.11, 1.62].0021.38 [1.05, 1.81].02
Nausea1.21 [1.04, 1.41].021.19 [0.97, 1.47].10
Anxiety1.30 [1.11, 1.51].0010.90 [0.66, 1.21].48
Depression1.48 [1.17, 1.64] <.0011.69 [1.15, 2.48].007
Dyspnea1.16 [0.99, 1.37].061.17 [0.93, 1.48].17
Wellbeing1.21 [1.00, 1.47].050.96 [0.73, 1.27].77
VentingAnxiety1.14 [1.03, 1.26].0091.10 [0.95, 1.28].22
Depression1.13 [1.02, 1.26].021.05 [0.90, 1.24].52
Behavioral disengagementSmall sample size
Self-distractionDyspnea0.91 [0.83, 0.99].030.92 [0.83, 1.01].09
Coping strategiesMedium-high vs. low utilization
Symptom burdenOR [95%CI]
Unadjusted
P-valueOR [95%CI]
Adjusted
P-valuea
AdaptiveProblem-focusedActive copingNo significant differences in symptom burden (>0.1)
PlanningPain1.07 [1.00, 1.15].060.99 [0.90, 1.09].87
Fatigue1.08 [1.00, 1.16].041.02 [0.91, 1.14].72
Anxiety1.16 [1.07, 1.26] <.0011.06 [0.93, 1.21].37
Depression1.15 {1.06, 1.26].0021.04 [0.90, 1.21].59
Drowsiness1.07 [0.99, 1.15].081.00 [0.89, 1.11].97
Sleep1.10 [1.02, 1.18].021.07 [0.96, 1.18].21
Wellbeing1.13 [1.04, 1.23].0041.04 [0.92, 1.17].54
Instrumental supportPain1.07 [1.00, 1.16].061.04 [0.96, 1.13].33
Drowsiness1.07 [0.99, 1.15].091.02 [0.93, 1.11].66
Dyspnea1.07 [0.99, 1.16].091.03 [0.94, 1.12].52
Sleep1.10 [1.02, 1.19].011.08 [0.99, 1.17].10
Wellbeing1.08 [0.99, 1.17].081.01 [0.91, 1.11].88
Emotion-focusedPositive reframingPain0.94 [0.87, 1.01].100.96 [0.88, 1.04].34
Fatigue0.94 [0.88, 1.01].100.95 [0.88, 1.03].22
Sleep1.07 [0.99, 1.16].071.16 [1.05, 1.27].002
Emotional supportPain0.92 [0.84, 1.01].080.98 [0.89, 1.09].77
Fatigue0.93 [0.85, 1.01].100.99 [0.89, 1.12].92
Nausea0.92 [0.83, 1.01].070.97 [0.86, 1.09].63
Anxiety0.85 [0.78, 0.93].0010.90 [0.78, 1.03].13
Depression0.86 [0.78, 0.95].0030.95 [0.81, 1.11].50
HumorAnxiety1.09 [0.99, 1.19].081.09 [0.99, 1.20].09
AcceptanceAnxiety0.84 [0.78, 0.93].0010.92 [0.77, 1.10].38
Depression0.82 [0.74, 0.95] <.0010.90 [0.74, 1.09].27
Nausea0.86 [0.77, 0.95].0040.90 [0.79, 1.03].12
ReligionDepression0.91 [0.83, 0.99].040.92 [0.83, 1.02].12
Appetite0.91 [0.84, 0.98].020.94 [0.86, 1.03].20
Sleep0.92 [0.85, 1.00].060.96 [0.87, 1.06].39
Wellbeing0.92 [0.85, 1.01].081.01 [0.90, 1.14].82
MaladaptiveSubstance useSmall sample size
Self-blameNo significant differences in symptom burden (>0.1)
DenialPain1.34 [1.11, 1.62].0021.38 [1.05, 1.81].02
Nausea1.21 [1.04, 1.41].021.19 [0.97, 1.47].10
Anxiety1.30 [1.11, 1.51].0010.90 [0.66, 1.21].48
Depression1.48 [1.17, 1.64] <.0011.69 [1.15, 2.48].007
Dyspnea1.16 [0.99, 1.37].061.17 [0.93, 1.48].17
Wellbeing1.21 [1.00, 1.47].050.96 [0.73, 1.27].77
VentingAnxiety1.14 [1.03, 1.26].0091.10 [0.95, 1.28].22
Depression1.13 [1.02, 1.26].021.05 [0.90, 1.24].52
Behavioral disengagementSmall sample size
Self-distractionDyspnea0.91 [0.83, 0.99].030.92 [0.83, 1.01].09

aWald test.

Abbreviation: ESAS, Edmonton Symptom Assessment System (<2.5% missing symptom ratings).

Table 4 reports significant unadjusted and adjusted odds ratio for patient characteristics associated with various coping strategies. Male patients were significantly less likely to engage in emotional (0.45 [0.27, 0.78], P = .004) and instrumental support (0.62 [0.41, 0.93], P = .02), positive framing (0.45 [0.30, 0.68], P < .0001), acceptance (0.40 [0.21, 0.83], P = .01), and religious coping (0.45 [0.29, 0.70], P < .0001) compared to females. With respect to maladaptive strategies, male patients reported less likely to adopt self-distraction (0.54 [0.34, 0.87], P = .01) and venting (0.38 [0.20, 0.73], P = .004). Patients with only a high school education or less were significantly less likely to incorporate planning (0.51 [0.31, 0.83], P = .006), humor (0.47 [0.25, 0.89], P = .02), and acceptance (0.42 [0.21, 0.83], P = .01) but more likely to adopt denial (7.66 [2.02, 29.0], P = .003) as compared with patients with some college experience or more. In addition, younger patients with cancer were more frequently to adopt at moderate to high frequency versus low planning as a coping strategy (mean age in years [SD]; 55.2 [11] vs. 57.8 [12], P = .03) as well as self-distraction (54 [13] vs. 58 [11], P = .003).

Table 4.

Characteristics associated with coping strategies among patients with cancer.

Patient characteristicAdaptive
Coping
styles
Moderate to high vs. low utilizationMaladaptive
Coping
styles
Moderate to high vs. low utilization
OR [95%CI]
Unadjusted
P-valueOR [95%CI]
Adjusted
P-valueaOR [95%CI]
Unadjusted
P-valueOR [95%CI]
Adjusted
P-valuea
Male vs. Female genderEmotional Support0.58 [0.35, 0.95].030.45 [0.27, 0.78].004Self-distraction0.50 [0.33, 0.76].0010.54 [0.34, 0.87].01
Instrumental support0.65 [0.43, 0.96].030.62 [0.41, 0.93].02Venting0.35 [0.19, 0.67].0010.38 [0.20, 0.73].004
Positive framing0.45 [0.30, 0.67]<.0010.45 [0.30, 0.68]<.0001
Acceptance0.43 [0.24, 0.77].0050.40 [0.21, 0.83].01
Religion0.44 [0.28, 0.68]<.0010.45 [0.29, 0.70]<.0001
High school or less vs. college or morePlanning0.43 [0.27, 0.67]<.0010.51 [0.31, 0.83].006Self-distraction0.62 [0.39, 0.99].050.62 [0.38, 1.01].06
Humor0.44 [0.24, 0.82].010.47 [0.25, 0.89].02Denial3.37 [1.21, 9.34].027.66 [2.02, 29.0].003
Active coping0.67 [0.43, 1.04].070.70 [0.44, 1.12].14
Acceptance0.53 [0.28, 1.01].050.42 [0.21, 0.83].01
Other minority vs. white ethnicityPlanning0.64 [0.41, 0.98].040.78 [0.46, 1.31].35
Active coping0.67 [0.43, 1.03].070.61 [0.38, 0.99].04
Single or other vs. married or living with a partnerEmotional support0.52 [0.32, 0.86].010.47 [0.28, 0.81].006Self-distraction1.55 [1.01, 2.37].041.62 [1.00, 2.62].05
Metastatic or recurrent vs. locally advancedActive coping0.40 [0.17, 0.95].040.29 [0.11, 0.80].02
Patient characteristicAdaptive
Coping
styles
Moderate to high vs. low utilizationMaladaptive
Coping
styles
Moderate to high vs. low utilization
OR [95%CI]
Unadjusted
P-valueOR [95%CI]
Adjusted
P-valueaOR [95%CI]
Unadjusted
P-valueOR [95%CI]
Adjusted
P-valuea
Male vs. Female genderEmotional Support0.58 [0.35, 0.95].030.45 [0.27, 0.78].004Self-distraction0.50 [0.33, 0.76].0010.54 [0.34, 0.87].01
Instrumental support0.65 [0.43, 0.96].030.62 [0.41, 0.93].02Venting0.35 [0.19, 0.67].0010.38 [0.20, 0.73].004
Positive framing0.45 [0.30, 0.67]<.0010.45 [0.30, 0.68]<.0001
Acceptance0.43 [0.24, 0.77].0050.40 [0.21, 0.83].01
Religion0.44 [0.28, 0.68]<.0010.45 [0.29, 0.70]<.0001
High school or less vs. college or morePlanning0.43 [0.27, 0.67]<.0010.51 [0.31, 0.83].006Self-distraction0.62 [0.39, 0.99].050.62 [0.38, 1.01].06
Humor0.44 [0.24, 0.82].010.47 [0.25, 0.89].02Denial3.37 [1.21, 9.34].027.66 [2.02, 29.0].003
Active coping0.67 [0.43, 1.04].070.70 [0.44, 1.12].14
Acceptance0.53 [0.28, 1.01].050.42 [0.21, 0.83].01
Other minority vs. white ethnicityPlanning0.64 [0.41, 0.98].040.78 [0.46, 1.31].35
Active coping0.67 [0.43, 1.03].070.61 [0.38, 0.99].04
Single or other vs. married or living with a partnerEmotional support0.52 [0.32, 0.86].010.47 [0.28, 0.81].006Self-distraction1.55 [1.01, 2.37].041.62 [1.00, 2.62].05
Metastatic or recurrent vs. locally advancedActive coping0.40 [0.17, 0.95].040.29 [0.11, 0.80].02

aWald test.

Table 4.

Characteristics associated with coping strategies among patients with cancer.

Patient characteristicAdaptive
Coping
styles
Moderate to high vs. low utilizationMaladaptive
Coping
styles
Moderate to high vs. low utilization
OR [95%CI]
Unadjusted
P-valueOR [95%CI]
Adjusted
P-valueaOR [95%CI]
Unadjusted
P-valueOR [95%CI]
Adjusted
P-valuea
Male vs. Female genderEmotional Support0.58 [0.35, 0.95].030.45 [0.27, 0.78].004Self-distraction0.50 [0.33, 0.76].0010.54 [0.34, 0.87].01
Instrumental support0.65 [0.43, 0.96].030.62 [0.41, 0.93].02Venting0.35 [0.19, 0.67].0010.38 [0.20, 0.73].004
Positive framing0.45 [0.30, 0.67]<.0010.45 [0.30, 0.68]<.0001
Acceptance0.43 [0.24, 0.77].0050.40 [0.21, 0.83].01
Religion0.44 [0.28, 0.68]<.0010.45 [0.29, 0.70]<.0001
High school or less vs. college or morePlanning0.43 [0.27, 0.67]<.0010.51 [0.31, 0.83].006Self-distraction0.62 [0.39, 0.99].050.62 [0.38, 1.01].06
Humor0.44 [0.24, 0.82].010.47 [0.25, 0.89].02Denial3.37 [1.21, 9.34].027.66 [2.02, 29.0].003
Active coping0.67 [0.43, 1.04].070.70 [0.44, 1.12].14
Acceptance0.53 [0.28, 1.01].050.42 [0.21, 0.83].01
Other minority vs. white ethnicityPlanning0.64 [0.41, 0.98].040.78 [0.46, 1.31].35
Active coping0.67 [0.43, 1.03].070.61 [0.38, 0.99].04
Single or other vs. married or living with a partnerEmotional support0.52 [0.32, 0.86].010.47 [0.28, 0.81].006Self-distraction1.55 [1.01, 2.37].041.62 [1.00, 2.62].05
Metastatic or recurrent vs. locally advancedActive coping0.40 [0.17, 0.95].040.29 [0.11, 0.80].02
Patient characteristicAdaptive
Coping
styles
Moderate to high vs. low utilizationMaladaptive
Coping
styles
Moderate to high vs. low utilization
OR [95%CI]
Unadjusted
P-valueOR [95%CI]
Adjusted
P-valueaOR [95%CI]
Unadjusted
P-valueOR [95%CI]
Adjusted
P-valuea
Male vs. Female genderEmotional Support0.58 [0.35, 0.95].030.45 [0.27, 0.78].004Self-distraction0.50 [0.33, 0.76].0010.54 [0.34, 0.87].01
Instrumental support0.65 [0.43, 0.96].030.62 [0.41, 0.93].02Venting0.35 [0.19, 0.67].0010.38 [0.20, 0.73].004
Positive framing0.45 [0.30, 0.67]<.0010.45 [0.30, 0.68]<.0001
Acceptance0.43 [0.24, 0.77].0050.40 [0.21, 0.83].01
Religion0.44 [0.28, 0.68]<.0010.45 [0.29, 0.70]<.0001
High school or less vs. college or morePlanning0.43 [0.27, 0.67]<.0010.51 [0.31, 0.83].006Self-distraction0.62 [0.39, 0.99].050.62 [0.38, 1.01].06
Humor0.44 [0.24, 0.82].010.47 [0.25, 0.89].02Denial3.37 [1.21, 9.34].027.66 [2.02, 29.0].003
Active coping0.67 [0.43, 1.04].070.70 [0.44, 1.12].14
Acceptance0.53 [0.28, 1.01].050.42 [0.21, 0.83].01
Other minority vs. white ethnicityPlanning0.64 [0.41, 0.98].040.78 [0.46, 1.31].35
Active coping0.67 [0.43, 1.03].070.61 [0.38, 0.99].04
Single or other vs. married or living with a partnerEmotional support0.52 [0.32, 0.86].010.47 [0.28, 0.81].006Self-distraction1.55 [1.01, 2.37].041.62 [1.00, 2.62].05
Metastatic or recurrent vs. locally advancedActive coping0.40 [0.17, 0.95].040.29 [0.11, 0.80].02

aWald test.

In an exploratory analysis, looking at patients with advanced cancer adopting either low versus moderate to high spiritual coping showed no association with CAGE questionnaire positivity ≥2 (19% vs. 17%, P = .67) or increased opioids use (morphine equivalent daily dosing ≥30) (56 vs. 60, P = .44), respectively.

Discussion

Most patients with advanced cancer seen in the SCC reported utilizing multiple adaptive coping strategies. In addition, patients with cancer who adopted problem-focused (apart from active coping) strategies or maladaptive coping including venting or denial had a higher symptom burden, while patients engaged in emotion-focused coping strategies reported less anxiety and depression. Other studies21-23 on coping in patients with cancer reported similar findings including acceptance being the most common implemented coping strategy, followed by emotional support, active coping, and religion. In addition, most people, including patients with cancer, do not fit neatly into any one strategic sub-group, but rather report adopting a variety of coping strategies, which may change over time and be affected by symptom burden. This flexibility may be important to develop resilience to the stressors experienced during a life-limiting illness.6 Further prospective longitudinal study is needed to determine whether counseling patients with cancer with advanced disease to adopt emotion-focused coping strategies, approach orientated as opposed to avoidant strategies, or the engagement of more than one healthy adaptive coping strategy will help to reduce their symptom burden, increase resilience, or improve QOL.

A minority of our patients reported unhealthy, negative coping strategies such as behavioral disengagement (avoidance), denial, and self-blame. The 2 most common unhealthy coping strategies reported were self-distraction and venting. It is unclear if these strategies lead to poor clinical outcomes; however, in our sample, these strategies were also associated with higher ratings of emotional distress with adoption of denial being associated with both higher pain and depression ratings. Similar findings have been noted in a systematic review examining coping styles and psychological distress, where disengaged coping was associated with higher psychological distress and worse QOL.24 Also, in patients with recently diagnosed lung or gastrointestinal cancers, the adoption of denial and self-blame were associated with worse QOL and increased anxiety and depression.25 In a recent longitudinal study of coping strategies in patients with hematological malignancies, avoidant coping (denial, self-blame, and behavioral disengagement) was associated with increased emotional distress.19

It is likely the degree to which such negative coping strategies are used to determine whether they are healthy or unhealthy. Self-distraction can be healthy, but when over-utilized, may be an indicator of denial, whereby the patient is not spending any time facing or avoiding what is happening. Similarly, venting can be healthy at times, but if used alone, may prevent healthy cognitive processing. Comparable findings have been noted in the literature to suggest sometimes positive coping strategies can be maladaptive. For example, religious/spiritual coping can be problematic when patients question their faith due to their illness,26 or problem-focused coping adaptive strategies can falter in the setting of an incurable disease. In our patient population of patients with advanced cancer, it is unclear if a higher symptom burden resulted in patients with cancer engaging in problem-focused coping or if the coping strategy itself resulted in increased distress. In addition, the ideal classification system for coping strategies, a complex phenomenon, as either adaptive versus maladaptive as opposed to approach-orientated or engaged versus avoidant, is unclear and more research is needed to determine which coping classification has the greatest clinical utility.

Gender differences were noted in our study and were significantly associated with different styles of coping. Research suggests an underlying difference between men and women with males displaying a “fight-or-flight” reaction or problem-focused coping to stress, whereas females adopt a “tend-and-befriend” reaction or emotion-focused coping mechanisms.27 In addition, minority patients with cancer or those with less than a high school education were significantly less likely to engage in planning which may have implications for why minorities may not engage in advanced care planning (ie, identifying healthcare proxies or completion of do-not-resuscitate order) as noted by other researchers.28,29 A study attempting to identify mediators of racial/ethnic differences noted that terminal illness knowledge, religiousness, or treatment preferences did not account for differences30, and more research is needed.

Findings related to substance use, an avoidant coping strategy, may have been limited by the means in which it was assessed by the 2 questions used in the brief-COPE Questionnaire. Despite the survey being confidential and staff trained to administer the questions in a non-judgmental manner, only 1% of our patient population reported moderate to high frequency of substance use as a coping strategy. In contrast, in the same patient population, CAGE positivity was noted to be 17.5% and the short form of the Screener and Opioid Assessment for Patients with Pain was positive in 18.1%.10 When the CAGE questionnaire is adapted to include drugs, the CAGE-AID, the sensitivity decreases.31 A positive CAGE-AID response rate was noted to be 10.5% in a prospective study and 11.4% in a large retrospective study.32 This suggests questions regarding non-medical opioid or alcohol use in times of stress may be perceived by patients to be too sensitive to disclose or they may also lack insight or awareness of the subconscious adoption of substance use as a coping mechanism. A confidential clinical interview by a psychologist or psychiatrist incorporating DSM-5 criteria is the gold standard to assess stigmatized behavior such as substance use disorders and may be needed to detect patients who engage in these harmful coping strategies.

The development of screening tools followed by a clinical interview are needed to assist in identifying the subset of patients with cancer engaging in unhealthy or avoidant coping strategies to triage psychological resources, which are often limited, to better assist patients with cancer in developing alternative, healthier coping strategies. Cognitive behavioral therapy (CBT) may be used to assist with redirecting patients’ thoughts and behavioral patterns to those that help them to process and develop, rather than avoid, healthy coping. This is also enhanced by our use of family meetings that include a patient with advanced cancer (when able), close family caregivers, and an interdisciplinary team, to assist with communication and to promote acceptance and other approach-orientated techniques. In a study evaluating early integration of palliative care (EIPC) for patients with advanced cancer, approach-orientated coping (acceptance, active coping, and positive reframing) mediated the effects of EIPC on improvements in symptoms and QOL.33

Another specific example of beneficial interventions includes a recent randomized trial reporting Mindfulness-Oriented Recovery Enhancement to be superior to psychotherapy in patients with chronic pain with respect to non-medical opioid use, opioid craving, and emotional distress.34 In addition, a recent study noted opioid tapering, defined as 15% or more relative reduction in mean daily opioid dose, for non-cancer patients on chronic opioid therapy, was associated with an increased risk for substance use disorders or a mental health crisis.35 This suggests that if an alternative healthy coping mechanism is not supplemented for substance (opioid) use, the risk of non-medical opioid use or emotional distress may counterintuitively increase in frequency.

Similarly, religious/spiritual coping assessment consisted of only 2 questions regarding prayer or meditation and comfort from religion or spiritual beliefs. These questions may not be sensitive enough to detect negative religious coping or spiritual pain. In a study examining 100 patients with cancer, almost all patients considered themselves spiritual (98%), spiritual pain was reported in 44% of patients, and a noted trend toward increased emotional distress.36 In our study, we also noted no difference in CAGE positivity or MEDD in patients with cancer who engaged in religious coping with moderate to high frequency. A recent study of the US religious landscape reported that among the religiosity domains, only frequency of service attendance was associated with substance use disorder including alcohol, tobacco, and cannabis,37 and more research is needed in patients with cancer.

Limitations of our study include the cross-sectional design, the high correlation between symptoms as measured by ESAS resulting in multicollinearity and less reliable multivariate models, and the small sample size of patients adopting maladaptive strategies at a moderate to high frequency. Although the brief COPE was used to not burden patients with cancer with too many questions, a more formal clinical interview using the DSM-5 criteria would ideally be used to assess for unhealthy coping mechanisms, such as substance use disorders.

Conclusion

Most patients with advanced cancer seen in an SCC by palliative healthcare providers reported utilizing multiple adaptive as opposed to maladaptive coping strategies. Screening tools for maladaptive or avoidant coping strategies, followed by a confidential clinical interview by a psychologist or psychiatrist, should be integrated to identify the minority of patients who may be more likely to use unhealthy coping strategies. Identifying patients with cancer who utilize unhealthy or avoidant coping is critical to direct psychological support and encourage alternative healthy strategies to cope with stress.

Acknowledgments

Hilda Cantu, Janet Williams assistance in data collection.

Funding

Bryan Fellman was supported in part by the National Institutes of Health through MD Anderson’s Cancer Center Support Grant CA016672.

Conflict of Interest

The authors indicated no financial relationships.

Author Contributions

Conception/design: R.D., M.A., S.B., C.C., E.B. Provision of study material or patients: R.D., M.A., A.R., S.B., J.A., A.H., C.C., D.H., E.B. Collection and/or assembly of data: R.D., D.H. Data analysis and interpretation: R.D., B.F., D.H., E.B. Manuscript writing: R.D., M.A., C.C., E.B. Final approval of manuscript: All authors.

Data Availability

The data underlying this article will be shared on reasonable request to the corresponding author.

References

1.

Carver
CS
,
Connor-Smith
J.
Personality and coping
.
Annu Rev Psychol
.
2010
;
61
:
679
704
. https://doi.org/10.1146/annurev.psych.093008.100352

2.

Folkman
S
,
Moskowitz
JT.
Coping: pitfalls and promise
.
Annu Rev Psychol
.
2004
;
55
:
745
774
. https://doi.org/10.1146/annurev.psych.55.090902.141456

3.

Carver
CS.
You want to measure coping but your protocol’s too long: consider the brief
.
Int J Behav Med
.
1997
;
4
:
92
100
.

4.

Endler
NS
,
Parker
JD.
Multidimensional assessment of coping; a critical evaluation
.
J Pers Soc Psychol
.
1990
;
58
(
5
):
844
854
. https://doi.org/10.1037//0022-3514.58.5.844

5.

Skinner
EA
,
Edge
K
,
Altman
J
, et al. .
Searching for the structure of coping: a review and critique of category systems for classifying ways of coping
.
Psycho Bull
.
2003
;
129
(
2
):
216
219
.

6.

Culver
JL
,
Arena
PL
,
Antoni
MH
,
Carver
CS.
Coping and distress among women under treatment for early stage breast cancer: comparing African Americans
.
Hispanic Non-Hispanic Whites Psychooncol
.
2002
;
11
(
6
):
495
504
. https://doi.org/10.1002/pon.615

7.

Keene Sarenmalm
E
,
Ohlen
J
,
Jonsson
T
, et al. .
Coping with recurrent breast cancer: Predictors of distressing symptoms and health-related quality of life
.
J Pain Symptom Mange
.
2007
;
34
(
1
):
24
39
.

8.

Hoyt
MA
,
Thomas
KS
,
Epstein
DR
,
Dirksen
SR.
Coping style and sleep quality in men with cancer
.
Ann Behav Med
.
2009
;
37
(
1
):
88
93
. https://doi.org/10.1007/s12160-009-9079-6

9.

Trevino
KM
,
Balboni
M
,
Zollfrank
A
,
Balboni
T
,
Prigerson
HG.
Negative religious coping as a correlate of suicidal ideation in patients with advanced cancer
.
Psychoonoclogy
.
2014
;
23
(
8
):
936
945
. https://doi.org/10.1002/pon.3505

10.

Dev
R
,
Kim
YJ
,
Reddy
A
, et al. .
Association between tobacco use, pain expression and coping strategies among patients with advanced cancer
.
Cancer
.
2019
;
125
(
1
):
153
160
. https://doi.org/10.1002/cncr.31783

11.

Greer
JA
,
Applebaum
JA
,
Jacobsen
JC
,
Temel
JS
,
Jackson
VA.
Understanding and addressing the role of coping in palliative care for patient with advanced cancer
.
J Clin Oncol
.
2020
;
38
(
9
):
915
925
.

12.

Carver
CS
,
Scheier
MF
,
Weintraub
JK.
Assessing coping strategies: a theoretically based approach
.
J Per Soc Psychol
.
1989
;
56
(
2
):
267
283
. https://doi.org/10.1037//0022-3514.56.2.267

13.

Bruera
E
,
Kuehn
N
,
Miller
MJ
,
Selmser
P
,
Macmillan
K.
The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients
.
J Palliat Care
.
1991
;
7
(
2
):
6
9
.

14.

Ewing
JA.
Detecting alcoholism. The CAGE questionnaire
.
JAMA
.
1984
;
252
(
14
):
1905
1907
. https://doi.org/10.1001/jama.252.14.1905

15.

Meyer
B.
Coping with severe mental illness: relations of the Brief COPE with symptoms, functioning, and well-being
.
J Psychopathol Behav Assess
.
2001
;
23
(
4
):
265
277
.

16.

Lehavot
K.
Coping strategies and health in a national sample of sexual minority women
.
Am J Orthopsychiat
.
2012
;
82
(
4
):
494
504
. https://doi.org/10.1111/j.1939-0025.2012.01178.x

17.

Cooper
C
,
Katona
C
,
Orrell
M
,
Livingston
G.
Coping strategies, anxiety and depression in caregivers of people with Alzheimer’s disease
.
Int J Geriatr Psychiat
.
2008
;
23
(
9
):
929
936
. https://doi.org/10.1002/gps.2007

18.

Lutgendorf
SK
,
Antoni
MH
,
Ironson
G
, et al. .
Changes in cognitive coping skills and social support during cognitive behavioral stress management intervention and distress outcomes in symptomatic human immunodeficiency virus (HIV)-seropositive gay men
.
Psychosom Med
.
1998
;
60
(
2
):
204
214
. https://doi.org/10.1097/00006842-199803000-00017

19.

Amonoo
HL
,
Daskalakis
E
,
Deary
EC
, et al. .
Relationship between longitudinal coping strategies and outcomes in patients with acute myeloid leukemia
.
J Natl Compr Canc Netw
.
2022
;
20
(
10
):
1116
1123
. https://doi.org/10.6004/jnccn.2022.7045

20.

Amonoo
HL
,
Bodd
MH
,
Reynolds
MJ
, et al. .
Coping strategies in patients with acute myeloid leukemia
.
Blood Adv
.
2022
;
6
(
7
):
2435
2442
. https://doi.org/10.1182/bloodadvances.2021005845

21.

Costanzo
ES
,
Lutgendort
SK
,
Rothrock
NE
,
Anderson
B.
coping and quality of life among women extensively treated for gynecologic cancer
.
Psychooncology
.
2006
;
15
(
2
):
132
142
.

22.

Price
MA
,
Bel
ML
,
Sommeijer
DW
, et al. .
Physical symptoms, coping styles and quality of life in recurrent ovarian cancer: a prospective population-based study over the last year of life
.
Gynecol Oncol
.
2013
;
130
(
1
):
162
168
.

23.

Thune-Boyle
ICV
,
Stygall
J
,
Keshtgar
MRS
,
Davidson
I
,
Newman
SP.
Religious coping strategies in patients diagnosed with breast cancer in the UK
.
Psychooncology
.
2011
;
20
(
7
):
771
782
.

24.

Morris
N
,
Moghaddam
N
,
Tickle
A
,
Biswas
S.
The relationship between coping style and psychological distress in people with head and neck cancer: a systematic review
.
Psychooncology
.
2008
;
27
(
3
):
734
747
. https://doi.org/10.1002/pon.4509

25.

Nipp
RD
,
El-Jawahri
A
,
Fishbein
JN
, et al. .
The relationship between coping strategies, quality of life, and mood in patients with incurable cancer
.
Cancer
.
2016
;
122
(
13
):
2110
2116
. https://doi.org/10.1002/cncr.30025

26.

Gall
TL
,
Bilodeau
C.
The role of positive and negative religious/spiritual coping in women’s adjustment to breast cancer: a longitudinal study
.
J Psychosoc Oncol
.
2020
;
38
(
1
):
103
117
.

27.

Wang
J
,
Korczykowski
M
,
Rao
H
, et al. .
Gender difference in neural response to psychological distress
.
Soc Cognit Affect Neurosci
.
2007
;
2
(
3
):
227
239
. https://doi.org/10.1093/scan/nsm018

28.

Phipps
E
,
True
G
,
Harris
D
, et al. .
Approaching the end of life: attitudes, preferences, and behaviors of African-American and white patient and their family caregivers
.
J Clin Oncol
.
2003
;
21
(
3
):
549
554
. https://doi.org/10.1200/JCO.2003.12.080

29.

Morrison
RS
,
Zayas
LH
,
Mulvihill
M
,
Baskin
SA
,
Meier
DE
.
, Meier DE Barriers to completion of health care proxies: an examination of ethnic differences
.
Arch Intern Med
.
1998
;
158
(
22
):
2493
2497
. https://doi.org/10.1001/archinte.158.22.2493

30.

Smith
AK
,
McCarthy
EP
,
Paulk
E
, et al. .
Racial and ethnic differences in advance care planning among patients with cancer: impact of terminal illness acknowledgment, religiousness, and treatment preferences
.
J Clin Oncol
.
2008
;
26
(
25
):
4131
4137
. https://doi.org/10.1200/JCO.2007.14.8452

31.

Brown
RL
,
Leonard
T
,
Saunders
LA
,
Papasouliotis
O.
The prevalence and detection of substance use disorders among inpatients ages 18 to 49: an opportunity for prevention
.
Prev Med
.
1998
;
27
(
1
):
101
110
. https://doi.org/10.1006/pmed.1997.0250

32.

Yennurajalingam
S
,
Arthur
J
,
Reddy
S
, et al. .
Frequency of and factors associated with nonmedical opioid use behavior among patients with cancer receiving opioids for cancer pain
.
JAMA Oncol
.
2021
;
7
(
3
):
404
411
. https://doi.org/10.1001/jamaoncol.2020.6789

33.

Greer
JA
,
Jacobs
JM
,
El-Jawahri
A
, et al. .
Role of patient coping strategies in understanding the effects of early palliative care on quality of life and mood
.
J Clin Oncol
.
2018
;
36
(
1
):
53
60
. https://doi.org/10.1200/JCO.2017.73.7221

34.

Garland
EL
,
Hanley
AW
,
Nakamura
Y
, et al. .
Mindfulness-oriented recovery enhancement vs supportive group therapy for co-occurring opioid misuse and chronic pain in primary care: a randomized clinical trial
.
JAMA Intern Med
.
2022
;
182
(
4
):
407
417
. https://doi.org/10.1001/jamainternmed.2022.0033

35.

Fenton
JJ
,
Magnan
E
,
Tseregounis
IE
, et al. .
Long-term risk of overdose or mental health crisis after opioid dose tapering
.
JAMA Network Open
.
2022
;
5
(
6
):
e2216726
. https://doi.org/10.1001/jamanetworkopen.2022.16726

36.

Delgado-Guay
MO
,
Hui
D
,
Parsons
HA
, et al. .
Spirituality, religiosity, and spiritual pain in advanced cancer patients
.
J Pain Symptom Manage
.
2011
;
41
(
6
):
986
994
.

37.

Livne
O
,
Wengrower
T
,
Feingold
D
, et al. .
Religiosity and substance use in U.S. adults: Findings from a large-scale national survey
.
Drug Alcohol Depend
.
2021
;
225
:
108796
. https://doi.org/10.1016/j.drugalcdep.2021.108796

Author notes

Rony Dev and Monica Agosta Contributed equally.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [email protected].